FI962948L - Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi - Google Patents

Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi Download PDF

Info

Publication number
FI962948L
FI962948L FI962948A FI962948A FI962948L FI 962948 L FI962948 L FI 962948L FI 962948 A FI962948 A FI 962948A FI 962948 A FI962948 A FI 962948A FI 962948 L FI962948 L FI 962948L
Authority
FI
Finland
Prior art keywords
active substances
pharmaceutically active
poorly soluble
soluble pharmaceutically
dissolving poorly
Prior art date
Application number
FI962948A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962948A0 (fi
FI962948A7 (fi
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI962948A0 publication Critical patent/FI962948A0/fi
Publication of FI962948A7 publication Critical patent/FI962948A7/fi
Publication of FI962948L publication Critical patent/FI962948L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962948A 1994-01-24 1995-01-24 Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi FI962948L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (3)

Publication Number Publication Date
FI962948A0 FI962948A0 (fi) 1996-07-23
FI962948A7 FI962948A7 (fi) 1996-07-23
FI962948L true FI962948L (fi) 1996-07-23

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962948A FI962948L (fi) 1994-01-24 1995-01-24 Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi

Country Status (14)

Country Link
EP (1) EP0741560A1 (cs)
JP (1) JPH09508128A (cs)
CN (1) CN1138827A (cs)
AU (1) AU706890B2 (cs)
BR (1) BR9506564A (cs)
CA (1) CA2181241C (cs)
CZ (1) CZ210496A3 (cs)
FI (1) FI962948L (cs)
MX (1) MX9602955A (cs)
NO (1) NO963052L (cs)
NZ (1) NZ279443A (cs)
PL (1) PL315635A1 (cs)
SK (1) SK96196A3 (cs)
WO (1) WO1995019759A1 (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
ATE429210T1 (de) 1998-01-20 2009-05-15 Applied Analytical Ind Inc Orale flüssige zusammensetzungen
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (fr) * 1999-07-29 2003-05-09 So Ge Val Sa Composition antipyretique concentree et stabilisee a usage veterinaire destine a etre incorporee a l'alimentation des animaux ainsi que procede d'incorporation de cette composition a l'eau de boisson d'animaux
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (de) * 2000-03-07 2001-09-13 Bayer Ag Acetylsalicylsäure-Lösungen
KR20020069387A (ko) * 2001-02-26 2002-09-04 진양제약주식회사 호박산독실아민 조성물 및 이 조성물을 함유한 연질캅셀제제
AU2002324579B2 (en) * 2001-07-31 2007-11-15 Wyeth Sucralose formulations to mask unpleasant tastes
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (zh) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 一种难溶性药物微丸的制备方法及包含该微丸的制剂
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (de) 2005-11-04 2007-05-10 Basf Ag Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen
EP1962908A2 (de) * 2005-12-09 2008-09-03 Basf Se Verwendung von polyvinyllactam-polyoxyalkylen-blockcopolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (ja) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd ソフトカプセル
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
SMT201700043T1 (it) 2010-01-28 2017-03-08 Eagle Pharmaceuticals Inc Formulazioni di bendamustina
CN104271135B (zh) 2012-03-20 2017-05-17 赛多斯有限责任公司 在要求减少施用容量的患者中治疗苯达莫司汀响应性状况的方法
JP6250628B2 (ja) 2012-03-20 2017-12-20 イーグル・ファーマシューティカルズ・インコーポレーテッド ベンダムスチンの製剤
NZ709958A (en) * 2013-02-28 2018-03-23 Pfizer Enhanced stability of novel liquid compositions
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (zh) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 一種製作難溶藥物固體劑型的方法
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
CN115957194B (zh) * 2021-10-08 2025-05-16 人福普克药业（武汉）有限公司 一种用于感冒软胶囊中内容物的溶剂体系及感冒软胶囊

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
PL315635A1 (en) 1996-11-25
AU1607595A (en) 1995-08-08
MX9602955A (es) 1997-06-28
FI962948A0 (fi) 1996-07-23
CA2181241A1 (en) 1995-07-27
NO963052D0 (no) 1996-07-22
CZ210496A3 (en) 1996-12-11
FI962948A7 (fi) 1996-07-23
EP0741560A1 (en) 1996-11-13
CA2181241C (en) 2000-04-25
CN1138827A (zh) 1996-12-25
NO963052L (no) 1996-09-24
JPH09508128A (ja) 1997-08-19
AU706890B2 (en) 1999-07-01
BR9506564A (pt) 1997-09-02
SK96196A3 (en) 1997-03-05
WO1995019759A1 (en) 1995-07-27
NZ279443A (en) 1998-04-27

Similar Documents

Publication Publication Date Title
FI962948A7 (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuot tamiseksi
FI960042L (fi) Farmaseuttisia valmisteita niukkaliukoisia aktiivisia aineita varten
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
FI952033A7 (fi) Farmakologisesti aktiiviset pyrrolopyrimidiinijohdannaiset
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
FI944602L (fi) Farmaseuttisesti aktiiviset bisyklis-heterosykliset amiinit
EE9800116A (et) Farmatseutiliselt aktiivsed kinasoliini ühendid
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
EE200000480A (et) Seade ja meetod manustamise toimumise indikatsiooniks
ATE187063T1 (de) Arzneimittel
EE200000438A (et) Farmatseutiliselt aktiivne morfolinool
FI946173A7 (fi) Menetelmä lääkeaineiden antotehon parantamiseksi muunnettujen saponiin ien avulla
DE69525148D1 (de) Pharmazeutische formulierung
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
FI924642L (fi) Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
DE69528843D1 (de) Pharmakologisch aktive 2-mercaptobenzimidazolderivate
FI103744B1 (fi) Menetelmä ja järjestely aktiivisuotimen kalibroimiseksi
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
IT1273469B (it) Montante laterale per quadro dei licci
NO940844D0 (no) Farmasöytisk aktive hydroksykarboksylsyrederivater
ATE244246T1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
EP0923564A4 (en) Pharmaceutical compounds
NO971879D0 (no) Preparat for transdermal administrasjon
FI960655A7 (fi) Aktiivinen kudostekijä sekä menetelmä sen valmistamiseksi